Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

investor.lilly.com

Eli Lilly and Company News Releases

Get the latest updates from Eli Lilly and Company News Releases directly as they happen.

Follow now 266 followers

Latest posts

Last updated 4 days ago

Statement: Eli Lilly has no affiliation with Mangoceuticals, Inc.

4 days ago

Eli Lilly and Company (NYSE: LLY) has no affiliation with Mangoceuticals, Inc...

Queer Eye's Tan France helps unthread obesity bias as part of Zepbound's (tirzepatide) 'Changing the Thread Collection'

8 days ago

New innovative campaign weaves science and storytelling to help reframe obesity as...

Lilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth

11 days ago

INDIANAPOLIS , Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE...

Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans

11 days ago

 Medicare beneficiaries with obesity or overweight will have access to   Zepbound and...

Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide

15 days ago

Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further...

Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance

19 days ago

Revenue in Q3 2025 increased 54% to $17.60 billion driven by volume...

LillyDirect and Walmart Pharmacy launch first retail pick-up option with direct-to-consumer pricing for Zepbound

20 days ago

Walmart , with nearly 4,600 pharmacies nationwide, will serve as the first...

Lilly partners with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients

20 days ago

New AI capabilities will help scientists   identify, optimize and validate new molecules...

Lilly's Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis

21 days ago

Omvoh now offers patients a simplified maintenance experience with one monthly injection...